Cargando…

Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices

IMPORTANCE: Undiagnosed atrial fibrillation (AF) is an important cause of stroke. Screening for AF using wrist-worn wearable devices may prevent strokes, but their cost-effectiveness is unknown. OBJECTIVE: To evaluate the cost-effectiveness of contemporary AF screening strategies, particularly wrist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wanyi, Khurshid, Shaan, Singer, Daniel E., Atlas, Steven J., Ashburner, Jeffrey M., Ellinor, Patrick T., McManus, David D., Lubitz, Steven A., Chhatwal, Jagpreet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356321/ https://www.ncbi.nlm.nih.gov/pubmed/36003419 http://dx.doi.org/10.1001/jamahealthforum.2022.2419

Ejemplares similares

Comparative Clinical Effectiveness of Population‐Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision‐Analytic Model
por: Khurshid, Shaan, et al.
Publicado: (2021)

Effect of clinic-based single-lead electrocardiogram rhythm assessment on oral anticoagulation prescriptions in patients with previously diagnosed atrial fibrillation
por: Ashburner, Jeffrey M., et al.
Publicado: (2023)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Characteristics and Attitudes of Wearable Device Users and Non-Users in a Large Healthcare System
por: Venn, Rachael A., et al.
Publicado: (2023)

Screening for undiagnosed atrial fibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial
por: Atlas, Steven J., et al.
Publicado: (2023)

Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study
por: Lubitz, Steven A., et al.
Publicado: (2022)

Comparative Effectiveness of Implantable Defibrillators for Asymptomatic Brugada Syndrome: A Decision‐Analytic Model
por: Khurshid, Shaan, et al.
Publicado: (2021)

Re‐CHARGE‐AF: Recalibration of the CHARGE‐AF Model for Atrial Fibrillation Risk Prediction in Patients With Acute Stroke
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Natural Language Processing to Improve Prediction of Incident Atrial Fibrillation Using Electronic Health Records
por: Ashburner, Jeffrey M., et al.
Publicado: (2022)

Personalized medicine and atrial fibrillation: will it ever happen?
por: Lubitz, Steven A, et al.
Publicado: (2012)

Wearable device use and technology preferences in cancer survivors with or at risk for atrial fibrillation
por: Faro, Jamie M., et al.
Publicado: (2022)

Genetic Loci Associated With Atrial Fibrillation: Relation to Left Atrial Structure in the Framingham Heart Study
por: Magnani, Jared W., et al.
Publicado: (2014)

Feasibility of atrial fibrillation detection from a novel wearable armband device
por: Bashar, Syed Khairul, et al.
Publicado: (2021)

Association of Wearable Device Use With Pulse Rate and Health Care Use in Adults With Atrial Fibrillation
por: Wang, Libo, et al.
Publicado: (2021)

Wearable accelerometer-derived physical activity and incident disease
por: Khurshid, Shaan, et al.
Publicado: (2022)

NExUS-Heart: Novel examinations using smart technologies for heart health—Data sharing from commercial wearable devices and telehealth engagement in participants with or at risk of atrial fibrillation
por: Nuvvula, Sri, et al.
Publicado: (2021)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

Whole Blood Gene Expression and Atrial Fibrillation: The Framingham Heart Study
por: Lin, Honghuang, et al.
Publicado: (2014)

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes
por: Yoneda, Zachary T., et al.
Publicado: (2021)

Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study
por: Long, Michelle T., et al.
Publicado: (2017)

Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study
por: Staerk, Laila, et al.
Publicado: (2017)

A Lifestyle Modification Program for Secondary Prevention of Atrial Fibrillation: A Pilot Study
por: Ashburner, Jeffrey M., et al.
Publicado: (2023)

Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study
por: Lin, Honghuang, et al.
Publicado: (2017)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study
por: Ko, Darae, et al.
Publicado: (2019)

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019)

Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

The Use of Artificial Intelligence to Predict the Development of Atrial Fibrillation
por: Pipilas, Daniel, et al.
Publicado: (2023)

Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes
por: Yoneda, Zachary T., et al.
Publicado: (2022)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Atrial Fibrillation Patterns and Risks of Subsequent Stroke, Heart Failure, or Death in the Community
por: Lubitz, Steven A., et al.
Publicado: (2013)

Keep your fingers on the PULsE: artificial intelligence to guide atrial fibrillation screening
por: Khurshid, Shaan, et al.
Publicado: (2022)

Survey of current perspectives on consumer-available digital health devices for detecting atrial fibrillation
por: Ding, Eric Y., et al.
Publicado: (2020)

Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants
por: Lin, Kueiyu Joshua, et al.
Publicado: (2023)

Cost Reduction Behaviors and Cost-Related Medication Nonadherence in Older Adults with Atrial Fibrillation
por: Bamgbade, Benita, et al.
Publicado: (2021)

Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases
por: Toumi, Asmae, et al.
Publicado: (2021)

Impact of a dedicated center for atrial fibrillation on resource utilization and costs
por: Medhekar, Ankit, et al.
Publicado: (2023)

A Genetic Risk Score for Atrial Fibrillation Predicts the Response to Catheter Ablation
por: Choe, Won-Seok, et al.
Publicado: (2018)

Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
por: Staerk, Laila, et al.
Publicado: (2018)

Blood Lipids and the Incidence of Atrial Fibrillation: The Multi‐Ethnic Study of Atherosclerosis and the Framingham Heart Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hqkdurp51ua0derpep4j891hqg